The UA DEM was the first among 18 sites in the U.S. to enroll a patient for the Pediatric Emergency Care Applied Research Network (PECARN) study “Application of Transcriptional Signatures for Diagnosis of Febrile Infants (BioSigs II).”
The UA DEM was the first among 18 sites in the U.S.
The UA DEM was the first among 18 sites in the U.S.
